Anthony Brown
Research Assistant
Brief Biography:
I’ve been working with Professor Barnes since 2007 and have mainly been working on the Phase 1 clinical candidate HCV vaccine studies that have been carried out in Oxford, looking at their immunogenicity in healthy volunteers and HCV patients.
I have also been involved in the NGS work of various pathogenic viruses, particularly HCV, that has been set up in collaboration with the Welcome Trust Centre for Human Genomics.
In addition to these main roles I have been looking at the immune response to HEV in HEV exposed individuals from Cornwall and Oxford in a collaboration with Dr Harry Dalton.
Research interests:
HCV sequencing and vaccination, all aspects of HEV infection and viral sequencing
Current projects:
PEACHI vaccine study, STOP-HCV viral sequencing and host immune response to HEV infection
Recent publications
The development of a pan-genotypic T cell vaccine against hepatitis C virus using heterologous prime-boost strategies
Journal article
Strain R. et al, (2025), Hepatology
Phase Ib/IIa randomized study of heterologous ChAdOx1-HBV/MVA-HBV therapeutic vaccination (VTP-300) as monotherapy and combined with low-dose nivolumab in virally-suppressed patients with CHB
Journal article
Tak WY. et al, (2024), Journal of Hepatology, 81, 949 - 959
Obesity differs from diabetes mellitus in antibody and T-cell responses post-COVID-19 recovery
Journal article
Ali M. et al, (2024), Clinical and Experimental Immunology, 218, 78 - 92
Immunogenicity of COVID‐19 vaccines in patients with follicular lymphoma receiving frontline chemoimmunotherapy
Journal article
Lim YJ. et al, (2024), British Journal of Haematology, 205, 440 - 451
Targeted metagenomics reveals association between severity and pathogen co-detection in infants with respiratory syncytial virus
Journal article
Lin G-L. et al, (2024), Nature Communications, 15